Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
CONTEXT: Women with polycystic ovary syndrome (PCOS) are known to suffer from hyperandrogenism and impaired glucose tolerance, as well as chronic inflammation, exposing them to an increased risk of cardiovascular diseases. However, the degree to which these hormonal and metabolic alterations persist after menopause (MP) is not well documented. OBJECTIVE: Our objective was to explore whether adverse metabolic and hormonal alterations persist after MP in women with PCOS. DESIGN: We conducted a cross-sectional university hospital-based study. PATIENTS AND INTERVENTIONS: Twenty-one pre-MP (n = 10) and post-MP (n = 11) women diagnosed with PCOS were compared with 29 healthy controls (pre-MP, n = 11; post-MP, n = 18). Two-hour oral glucose tolerance tests were performed, and ovarian steroid secretion capacity was assessed (human chorionic gonadotropin tests). Areas under the curves (AUC) were calculated. RESULTS: Both pre-MP and post-MP women with PCOS had increased insulin response in oral glucose tolerance tests (AUC(ins) pre-MP = 6733.7 vs. 3382.9; post-MP = 9732.1 vs. 3265.3) and were more insulin resistant than controls. Androgen secretion capacity was increased before and after MP in PCOS (AUC of androstenedione; pre-MP: 1218.4 vs. 853.2; post-MP: 1000.0 vs. 531.3). High-sensitivity C-reactive protein remained elevated after MP in PCOS (pre-MP: 1.3 vs. 0.7; post-MP: 1.4 vs. 0.9 mg/liter). Adjustment for body mass index did not alter the results except for glucose metabolism. CONCLUSIONS: The results indicate that impaired glucose metabolism, enhanced ovarian androgen secretion, and chronic inflammation observed in pre-MP women with PCOS persist after menopausal transition emphasizing life-long health risks related to this syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women with PCOS in their 40s and older have a higher prevalence of hypertension and triglycerides54 and are more likely to have insulin resistance compared with women without PCOS.”
From 'I'm usually being my own doctor': women's experiences of managing polycystic ovary syndrome in Canada (2023) · cites this paper as [55]
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427 · cited 1×
“(13) showed that women with self-reported histories of irregular menses and current biochemical evidence of hyperandrogenism were more insulin resistant and more often had T2DM when compared with”
BackgroundRetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“(28) [fasting insulin (milli-International units per liter) fasting glucose (millimoles per liter)/22.”
Background(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 4×
“the Matsuda index, described by Matsuda and DeFronzo (29), was calculated according to the following equation: 10,000/ [(fasting G fasting I) (Gmeanogtt Imeanogtt)], where G is glucose, and I is insulin.”
BackgroundMethodInfluentialThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712 · cited 1×
“Polycystic ovary syndrome (PCOS) manifested by menstrual irregularities, hyperandrogenism, and polycystic ovaries is the most common endocrine disorder among women of reproductive age (1, 2).”
BackgroundCLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506 · cited 1×
“A diagnosis of PCOS was made if at least two of the following criteria were met: 1) oligomenorrhea (intermenstrual interval 35 d) or irregular menstruation (menstrual interval 7 d different from one period to another), 2) hyperandrogenism [hirsutism score 8 (Ferriman-Gallwey score) (23), acne, or serum testosterone (T…”
MethodMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799 · cited 1×
“Polycystic ovary syndrome (PCOS) manifested by menstrual irregularities, hyperandrogenism, and polycystic ovaries is the most common endocrine disorder among women of reproductive age (1, 2).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 3×
“The Matsuda index, reflecting whole-body insulin sensitivity, was lower in women with PCOS in both age groups, and the same difference was observed in ISI (at 0 and 2 h) in the J Clin Endocrinol Metab, June 2011, 96(6):1827–1834 jcem.”
BackgroundResultInfluential
Cited by
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Schmidt, J., Landin-Wilhelmsen, K., Brännström, M., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1677 · Cited by 241
“tion (33), where the HOMA index was increased in the 11”
BackgroundNewman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 172
Metadata
- Authors
- Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S.
- Affiliations
- Oulu University Hospital (FI)
- Turku University Hospital (FI)
- Corresponding author
- Tapanainen, Juha S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1827-1834
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2017057701
- Cited by
- 108
- References
- 50
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 11 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 10 · 2012: 10
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- polycystic ovary syndrome, menopause, insulin resistance, impaired glucose tolerance, hyperandrogenism, androstenedione, chronic inflammation, C-reactive protein, cardiovascular risk, metabolic changes
- MeSH terms
- Analysis of Variance, Blood Glucose, Body Composition, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Follicle Stimulating Hormone, Glucose Tolerance Test, Chorionic Gonadotropin, Humans, Inflammation, Inhibins, Luteinizing Hormone, Middle Aged, Polycystic Ovary Syndrome, Sex Hormone-Binding Globulin, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS. https://app.cochat.ai/papers/10.1210/jc.2011-0039
- The paper
- Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011). Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2011-0039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.